Report Detail

Request for Sample of this report

Medical Industry Global Lentiviral Vector (LVV) CDMO Services Market Growth (Status and Outlook) 2022-2028

  • RnM4498099
    • |
  • 12 December, 2022
    • |
  • Global
    • |
  • 122 Pages
    • |
  • LPI(LP Information)
    • |
  • Medical Industry

The global market for Lentiviral Vector (LVV) CDMO Services is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC Lentiviral Vector (LVV) CDMO Services market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States Lentiviral Vector (LVV) CDMO Services market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe Lentiviral Vector (LVV) CDMO Services market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China Lentiviral Vector (LVV) CDMO Services market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key Lentiviral Vector (LVV) CDMO Services players cover Thermo Fisher Scientific, GenScript ProBio, Hillgene, Charles River Laboratories and Ubrigene, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage
This latest report provides a deep insight into the global Lentiviral Vector (LVV) CDMO Services market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global Lentiviral Vector (LVV) CDMO Services market, with both quantitative and qualitative data, to help readers understand how the Lentiviral Vector (LVV) CDMO Services market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.

Market Segmentation:
The study segments the Lentiviral Vector (LVV) CDMO Services market and forecasts the market size by Type (IIT Grade, IND Grade and Clinical Trial Grade), by Application (Biopharmaceutical Company and Academic Scientific Research Institution.), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
IIT Grade
IND Grade
Clinical Trial Grade
Commercial Production Grade

Segmentation by application
Biopharmaceutical Company
Academic Scientific Research Institution

Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Major companies covered
Thermo Fisher Scientific
GenScript ProBio
Hillgene
Charles River Laboratories
Ubrigene
Obio Technology (shanghai)
Genesail Biotech (Shanghai)
Wuxi Apptec
Porton Advanced Solutions
Pharmaron
Asymchem Laboratories (Tianjin)
Merck
VectorBuilder
Yposkesi
Flash Therapeutics
VIVEBiotech
Miltenyi Bioindustry
Genezen
Miltenyi Biotec
Exthera
Catalent

Chapter Introduction
Chapter 1: Scope of Lentiviral Vector (LVV) CDMO Services, Research Methodology, etc.
Chapter 2: Executive Summary, global Lentiviral Vector (LVV) CDMO Services market size and CAGR, Lentiviral Vector (LVV) CDMO Services market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Lentiviral Vector (LVV) CDMO Services revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Lentiviral Vector (LVV) CDMO Services revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Lentiviral Vector (LVV) CDMO Services market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Thermo Fisher Scientific, GenScript ProBio, Hillgene, Charles River Laboratories, Ubrigene, Obio Technology (shanghai), Genesail Biotech (Shanghai), Wuxi Apptec and Porton Advanced Solutions, etc.
Chapter 14: Research Findings and Conclusion


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Lentiviral Vector (LVV) CDMO Services Market Size 2017-2028
    • 2.1.2 Lentiviral Vector (LVV) CDMO Services Market Size CAGR by Region 2017 VS 2022 VS 2028
  • 2.2 Lentiviral Vector (LVV) CDMO Services Segment by Type
    • 2.2.1 IIT Grade
    • 2.2.2 IND Grade
    • 2.2.3 Clinical Trial Grade
    • 2.2.4 Commercial Production Grade
  • 2.3 Lentiviral Vector (LVV) CDMO Services Market Size by Type
    • 2.3.1 Lentiviral Vector (LVV) CDMO Services Market Size CAGR by Type (2017 VS 2022 VS 2028)
    • 2.3.2 Global Lentiviral Vector (LVV) CDMO Services Market Size Market Share by Type (2017-2022)
  • 2.4 Lentiviral Vector (LVV) CDMO Services Segment by Application
    • 2.4.1 Biopharmaceutical Company
    • 2.4.2 Academic Scientific Research Institution
  • 2.5 Lentiviral Vector (LVV) CDMO Services Market Size by Application
    • 2.5.1 Lentiviral Vector (LVV) CDMO Services Market Size CAGR by Application (2017 VS 2022 VS 2028)
    • 2.5.2 Global Lentiviral Vector (LVV) CDMO Services Market Size Market Share by Application (2017-2022)

3 Lentiviral Vector (LVV) CDMO Services Market Size by Player

  • 3.1 Lentiviral Vector (LVV) CDMO Services Market Size Market Share by Players
    • 3.1.1 Global Lentiviral Vector (LVV) CDMO Services Revenue by Players (2020-2022)
    • 3.1.2 Global Lentiviral Vector (LVV) CDMO Services Revenue Market Share by Players (2020-2022)
  • 3.2 Global Lentiviral Vector (LVV) CDMO Services Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Lentiviral Vector (LVV) CDMO Services by Regions

  • 4.1 Lentiviral Vector (LVV) CDMO Services Market Size by Regions (2017-2022)
  • 4.2 Americas Lentiviral Vector (LVV) CDMO Services Market Size Growth (2017-2022)
  • 4.3 APAC Lentiviral Vector (LVV) CDMO Services Market Size Growth (2017-2022)
  • 4.4 Europe Lentiviral Vector (LVV) CDMO Services Market Size Growth (2017-2022)
  • 4.5 Middle East & Africa Lentiviral Vector (LVV) CDMO Services Market Size Growth (2017-2022)

5 Americas

  • 5.1 Americas Lentiviral Vector (LVV) CDMO Services Market Size by Country (2017-2022)
  • 5.2 Americas Lentiviral Vector (LVV) CDMO Services Market Size by Type (2017-2022)
  • 5.3 Americas Lentiviral Vector (LVV) CDMO Services Market Size by Application (2017-2022)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Lentiviral Vector (LVV) CDMO Services Market Size by Region (2017-2022)
  • 6.2 APAC Lentiviral Vector (LVV) CDMO Services Market Size by Type (2017-2022)
  • 6.3 APAC Lentiviral Vector (LVV) CDMO Services Market Size by Application (2017-2022)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Lentiviral Vector (LVV) CDMO Services by Country (2017-2022)
  • 7.2 Europe Lentiviral Vector (LVV) CDMO Services Market Size by Type (2017-2022)
  • 7.3 Europe Lentiviral Vector (LVV) CDMO Services Market Size by Application (2017-2022)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Lentiviral Vector (LVV) CDMO Services by Region (2017-2022)
  • 8.2 Middle East & Africa Lentiviral Vector (LVV) CDMO Services Market Size by Type (2017-2022)
  • 8.3 Middle East & Africa Lentiviral Vector (LVV) CDMO Services Market Size by Application (2017-2022)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Global Lentiviral Vector (LVV) CDMO Services Market Forecast

  • 10.1 Global Lentiviral Vector (LVV) CDMO Services Forecast by Regions (2023-2028)
    • 10.1.1 Global Lentiviral Vector (LVV) CDMO Services Forecast by Regions (2023-2028)
    • 10.1.2 Americas Lentiviral Vector (LVV) CDMO Services Forecast
    • 10.1.3 APAC Lentiviral Vector (LVV) CDMO Services Forecast
    • 10.1.4 Europe Lentiviral Vector (LVV) CDMO Services Forecast
    • 10.1.5 Middle East & Africa Lentiviral Vector (LVV) CDMO Services Forecast
  • 10.2 Americas Lentiviral Vector (LVV) CDMO Services Forecast by Country (2023-2028)
    • 10.2.1 United States Lentiviral Vector (LVV) CDMO Services Market Forecast
    • 10.2.2 Canada Lentiviral Vector (LVV) CDMO Services Market Forecast
    • 10.2.3 Mexico Lentiviral Vector (LVV) CDMO Services Market Forecast
    • 10.2.4 Brazil Lentiviral Vector (LVV) CDMO Services Market Forecast
  • 10.3 APAC Lentiviral Vector (LVV) CDMO Services Forecast by Region (2023-2028)
    • 10.3.1 China Lentiviral Vector (LVV) CDMO Services Market Forecast
    • 10.3.2 Japan Lentiviral Vector (LVV) CDMO Services Market Forecast
    • 10.3.3 Korea Lentiviral Vector (LVV) CDMO Services Market Forecast
    • 10.3.4 Southeast Asia Lentiviral Vector (LVV) CDMO Services Market Forecast
    • 10.3.5 India Lentiviral Vector (LVV) CDMO Services Market Forecast
    • 10.3.6 Australia Lentiviral Vector (LVV) CDMO Services Market Forecast
  • 10.4 Europe Lentiviral Vector (LVV) CDMO Services Forecast by Country (2023-2028)
    • 10.4.1 Germany Lentiviral Vector (LVV) CDMO Services Market Forecast
    • 10.4.2 France Lentiviral Vector (LVV) CDMO Services Market Forecast
    • 10.4.3 UK Lentiviral Vector (LVV) CDMO Services Market Forecast
    • 10.4.4 Italy Lentiviral Vector (LVV) CDMO Services Market Forecast
    • 10.4.5 Russia Lentiviral Vector (LVV) CDMO Services Market Forecast
  • 10.5 Middle East & Africa Lentiviral Vector (LVV) CDMO Services Forecast by Region (2023-2028)
    • 10.5.1 Egypt Lentiviral Vector (LVV) CDMO Services Market Forecast
    • 10.5.2 South Africa Lentiviral Vector (LVV) CDMO Services Market Forecast
    • 10.5.3 Israel Lentiviral Vector (LVV) CDMO Services Market Forecast
    • 10.5.4 Turkey Lentiviral Vector (LVV) CDMO Services Market Forecast
    • 10.5.5 GCC Countries Lentiviral Vector (LVV) CDMO Services Market Forecast
  • 10.6 Global Lentiviral Vector (LVV) CDMO Services Forecast by Type (2023-2028)
  • 10.7 Global Lentiviral Vector (LVV) CDMO Services Forecast by Application (2023-2028)

11 Key Players Analysis

  • 11.1 Thermo Fisher Scientific
    • 11.1.1 Thermo Fisher Scientific Company Information
    • 11.1.2 Thermo Fisher Scientific Lentiviral Vector (LVV) CDMO Services Product Offered
    • 11.1.3 Thermo Fisher Scientific Lentiviral Vector (LVV) CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
    • 11.1.4 Thermo Fisher Scientific Main Business Overview
    • 11.1.5 Thermo Fisher Scientific Latest Developments
  • 11.2 GenScript ProBio
    • 11.2.1 GenScript ProBio Company Information
    • 11.2.2 GenScript ProBio Lentiviral Vector (LVV) CDMO Services Product Offered
    • 11.2.3 GenScript ProBio Lentiviral Vector (LVV) CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
    • 11.2.4 GenScript ProBio Main Business Overview
    • 11.2.5 GenScript ProBio Latest Developments
  • 11.3 Hillgene
    • 11.3.1 Hillgene Company Information
    • 11.3.2 Hillgene Lentiviral Vector (LVV) CDMO Services Product Offered
    • 11.3.3 Hillgene Lentiviral Vector (LVV) CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
    • 11.3.4 Hillgene Main Business Overview
    • 11.3.5 Hillgene Latest Developments
  • 11.4 Charles River Laboratories
    • 11.4.1 Charles River Laboratories Company Information
    • 11.4.2 Charles River Laboratories Lentiviral Vector (LVV) CDMO Services Product Offered
    • 11.4.3 Charles River Laboratories Lentiviral Vector (LVV) CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
    • 11.4.4 Charles River Laboratories Main Business Overview
    • 11.4.5 Charles River Laboratories Latest Developments
  • 11.5 Ubrigene
    • 11.5.1 Ubrigene Company Information
    • 11.5.2 Ubrigene Lentiviral Vector (LVV) CDMO Services Product Offered
    • 11.5.3 Ubrigene Lentiviral Vector (LVV) CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
    • 11.5.4 Ubrigene Main Business Overview
    • 11.5.5 Ubrigene Latest Developments
  • 11.6 Obio Technology (shanghai)
    • 11.6.1 Obio Technology (shanghai) Company Information
    • 11.6.2 Obio Technology (shanghai) Lentiviral Vector (LVV) CDMO Services Product Offered
    • 11.6.3 Obio Technology (shanghai) Lentiviral Vector (LVV) CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
    • 11.6.4 Obio Technology (shanghai) Main Business Overview
    • 11.6.5 Obio Technology (shanghai) Latest Developments
  • 11.7 Genesail Biotech (Shanghai)
    • 11.7.1 Genesail Biotech (Shanghai) Company Information
    • 11.7.2 Genesail Biotech (Shanghai) Lentiviral Vector (LVV) CDMO Services Product Offered
    • 11.7.3 Genesail Biotech (Shanghai) Lentiviral Vector (LVV) CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
    • 11.7.4 Genesail Biotech (Shanghai) Main Business Overview
    • 11.7.5 Genesail Biotech (Shanghai) Latest Developments
  • 11.8 Wuxi Apptec
    • 11.8.1 Wuxi Apptec Company Information
    • 11.8.2 Wuxi Apptec Lentiviral Vector (LVV) CDMO Services Product Offered
    • 11.8.3 Wuxi Apptec Lentiviral Vector (LVV) CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
    • 11.8.4 Wuxi Apptec Main Business Overview
    • 11.8.5 Wuxi Apptec Latest Developments
  • 11.9 Porton Advanced Solutions
    • 11.9.1 Porton Advanced Solutions Company Information
    • 11.9.2 Porton Advanced Solutions Lentiviral Vector (LVV) CDMO Services Product Offered
    • 11.9.3 Porton Advanced Solutions Lentiviral Vector (LVV) CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
    • 11.9.4 Porton Advanced Solutions Main Business Overview
    • 11.9.5 Porton Advanced Solutions Latest Developments
  • 11.10 Pharmaron
    • 11.10.1 Pharmaron Company Information
    • 11.10.2 Pharmaron Lentiviral Vector (LVV) CDMO Services Product Offered
    • 11.10.3 Pharmaron Lentiviral Vector (LVV) CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
    • 11.10.4 Pharmaron Main Business Overview
    • 11.10.5 Pharmaron Latest Developments
  • 11.11 Asymchem Laboratories (Tianjin)
    • 11.11.1 Asymchem Laboratories (Tianjin) Company Information
    • 11.11.2 Asymchem Laboratories (Tianjin) Lentiviral Vector (LVV) CDMO Services Product Offered
    • 11.11.3 Asymchem Laboratories (Tianjin) Lentiviral Vector (LVV) CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
    • 11.11.4 Asymchem Laboratories (Tianjin) Main Business Overview
    • 11.11.5 Asymchem Laboratories (Tianjin) Latest Developments
  • 11.12 Merck
    • 11.12.1 Merck Company Information
    • 11.12.2 Merck Lentiviral Vector (LVV) CDMO Services Product Offered
    • 11.12.3 Merck Lentiviral Vector (LVV) CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
    • 11.12.4 Merck Main Business Overview
    • 11.12.5 Merck Latest Developments
  • 11.13 VectorBuilder
    • 11.13.1 VectorBuilder Company Information
    • 11.13.2 VectorBuilder Lentiviral Vector (LVV) CDMO Services Product Offered
    • 11.13.3 VectorBuilder Lentiviral Vector (LVV) CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
    • 11.13.4 VectorBuilder Main Business Overview
    • 11.13.5 VectorBuilder Latest Developments
  • 11.14 Yposkesi
    • 11.14.1 Yposkesi Company Information
    • 11.14.2 Yposkesi Lentiviral Vector (LVV) CDMO Services Product Offered
    • 11.14.3 Yposkesi Lentiviral Vector (LVV) CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
    • 11.14.4 Yposkesi Main Business Overview
    • 11.14.5 Yposkesi Latest Developments
  • 11.15 Flash Therapeutics
    • 11.15.1 Flash Therapeutics Company Information
    • 11.15.2 Flash Therapeutics Lentiviral Vector (LVV) CDMO Services Product Offered
    • 11.15.3 Flash Therapeutics Lentiviral Vector (LVV) CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
    • 11.15.4 Flash Therapeutics Main Business Overview
    • 11.15.5 Flash Therapeutics Latest Developments
  • 11.16 VIVEBiotech
    • 11.16.1 VIVEBiotech Company Information
    • 11.16.2 VIVEBiotech Lentiviral Vector (LVV) CDMO Services Product Offered
    • 11.16.3 VIVEBiotech Lentiviral Vector (LVV) CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
    • 11.16.4 VIVEBiotech Main Business Overview
    • 11.16.5 VIVEBiotech Latest Developments
  • 11.17 Miltenyi Bioindustry
    • 11.17.1 Miltenyi Bioindustry Company Information
    • 11.17.2 Miltenyi Bioindustry Lentiviral Vector (LVV) CDMO Services Product Offered
    • 11.17.3 Miltenyi Bioindustry Lentiviral Vector (LVV) CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
    • 11.17.4 Miltenyi Bioindustry Main Business Overview
    • 11.17.5 Miltenyi Bioindustry Latest Developments
  • 11.18 Genezen
    • 11.18.1 Genezen Company Information
    • 11.18.2 Genezen Lentiviral Vector (LVV) CDMO Services Product Offered
    • 11.18.3 Genezen Lentiviral Vector (LVV) CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
    • 11.18.4 Genezen Main Business Overview
    • 11.18.5 Genezen Latest Developments
  • 11.19 Miltenyi Biotec
    • 11.19.1 Miltenyi Biotec Company Information
    • 11.19.2 Miltenyi Biotec Lentiviral Vector (LVV) CDMO Services Product Offered
    • 11.19.3 Miltenyi Biotec Lentiviral Vector (LVV) CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
    • 11.19.4 Miltenyi Biotec Main Business Overview
    • 11.19.5 Miltenyi Biotec Latest Developments
  • 11.20 Exthera
    • 11.20.1 Exthera Company Information
    • 11.20.2 Exthera Lentiviral Vector (LVV) CDMO Services Product Offered
    • 11.20.3 Exthera Lentiviral Vector (LVV) CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
    • 11.20.4 Exthera Main Business Overview
    • 11.20.5 Exthera Latest Developments
  • 11.21 Catalent
    • 11.21.1 Catalent Company Information
    • 11.21.2 Catalent Lentiviral Vector (LVV) CDMO Services Product Offered
    • 11.21.3 Catalent Lentiviral Vector (LVV) CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
    • 11.21.4 Catalent Main Business Overview
    • 11.21.5 Catalent Latest Developments

12 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on Lentiviral Vector (LVV) CDMO Services. Industry analysis & Market Report on Lentiviral Vector (LVV) CDMO Services is a syndicated market report, published as Global Lentiviral Vector (LVV) CDMO Services Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Lentiviral Vector (LVV) CDMO Services market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
2,829.18
5,658.36
3,407.46
6,814.92
558,845.40
1,117,690.80
308,904.00
617,808.00
Credit card Logo
Sample Question Discount Download PDF

Related Reports

Reason to Buy

  • Trusted By Leaders

    Top executives from leading companies purchase research reports from us. 

  • Shop With Confidence

    We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

  • Customer Centric

    Need assistance related to your research requirements? We are just a phone call or an email away.

  • Personalized Solutions

    Our experienced research specialists are here to help you locate the right reports for your need.

  • Secure Checkout

    Shop without being worried about safety & security of your transactions.
    •

Request for Sample of this report

Reports and Markets

mcafree

Contact Us

+1-352-353-0818 (US)

info@reportsandmarkets.com

Support

EMAIL US

Newsletter

KEEP UP TO DATE ON ALL THE LATEST REPORTS


maxmind_logo